Programmable nucleic acid nanoparticles boost vaccine immune responses as effectively as standard adjuvants in mice while ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

A research team at The University of Osaka revealed that the loss of heterochromatin can cause a chain reaction leading to ...

One of the hallmarks of Alzheimer's disease is the clumping of proteins called Tau, which form tangled fibrils in the brain.

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...

Guanidine is an organic compound primarily used as a denaturing reagent to disrupt the structures of proteins and nucleic ...

CSIC, reveals how the bacterium that causes cholera activates its virulence programme, uncovering a single amino acid as a ...

Lysosomes are the recycling centers of human cells. Larger molecules are broken down inside the membrane-enclosed vesicles. Malfunctions can lead to neurodegenerative diseases such as Parkinson's.

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ –During the 2026 J.P. Morgan Healthcare Conference (JPM), the 2026 China FIC Innovation & Collaboration Summit was successfully held in San Francisco, the ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

When scientists sliced into a block of Siberian permafrost and pulled out a woolly mammoth nicknamed Yuka, they expected to ...